pubmed.ncbi.nlm.nih.gov

Development of Clinical Trials to Extend Healthy Lifespan - PubMed

Development of Clinical Trials to Extend Healthy Lifespan

Jamie N Justice et al. Cardiovasc Endocrinol Metab. 2018 Dec.

Abstract

Significant progress in defining the biology of aging, particularly in animal models, supports the geroscience hypothesis, which posits that by therapeutically targeting biological aging, the onset of multiple age-related diseases can be delayed "en suite". Geroscience investigators are preparing to test this hypothesis in humans for the first time. In this review, we describe development of large-scale clinical trials designed to determine if multiple age-related health conditions can be simultaneously alleviated with interventions targeting the underlying biology of aging. We describe the rationale and collaborative, consensus building approach used to design the first aging outcomes trial called Targeting Aging with Metformin (TAME). Through this case study, we outline features that could be more broadly extended to other geroscience-guided clinical trials, including a process for selecting biochemical and molecular markers of biologic age and we provide a perspective on the potential impact of clinical trials targeting aging.

Keywords: aging; biomarkers; clinical trials; geroscience; healthspan; multi-morbidity.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None

Figures

Fig. 1
Fig. 1

Geroscience hypothesis. Aging exponentially increases the occurrence of major diseases or death in men and women. The geroscience hypothesis is that by targeting the fundamental biologic aging processes that lead to this collective increase in risk, the onset of many age-related diseases and other phenotypes of aging in humans can be delayed collectively.

Similar articles

Cited by

References

    1. St Sauver JL, Boyd CM, Grossardt BR, Bobo WV, Finney Rutten LJ, Roger VL, et al. Risk of developing multimorbidity across all ages in an historical cohort study: differences by sex and ethnicity. BMJ Open 2015; 5:e006413. - PMC - PubMed
    1. Services UDoHaH, Prevention CfDCa, Statistics NCfH. Health, United States, 2016: With Chartbook on Long-term Trends in Health. Hyattsville, MD: National Center for Health Statistics, 2017 Contract No.: DHHS Publication No. 2017-1232; 2017. - PubMed
    1. DALYs GBD, Collaborators H. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016; 388:1603–1658. - PMC - PubMed
    1. Goldman DP, Cutler D, Rowe JW, Michaud PC, Sullivan J, Peneva D, Olshansky SJ. Substantial health and economic returns from delayed aging may warrant a new focus for medical research. Health Aff (Millwood) 2013; 32:1698–1705. - PMC - PubMed
    1. Espeland MA, Crimmins EM, Grossardt BR, Crandall JP, Gelfond JA, Harris TB, et al. Multimorbidity clinical trials C. Clinical trials targeting aging and age-related multimorbidity. J Gerontol A Biol Sci Med Sci 2017; 72:355–361. - PMC - PubMed

LinkOut - more resources